Anti-ageing drugs are coming – an expert explains

September 12, 2018 by Richard Faragher, The Conversation
They may not be as far off as you think. Credit: Pixelbliss/Shutterstock

There will be almost 10 billion people living on Earth by 2050 and 2 billion of them will be over the age of 60. Growing old is the primary risk factor for multiple chronic and life threatening conditions such as diabetes or cardiovascular disease. This burdensome morbidity is the most distressing aspect of old age – compromising individual independence and straining collective healthcare systems.

To help older people flourish, we must understand the biology of ageing at the tissue, cellular and molecular levels, and then turn that understanding into new preventative medicines. Indeed, it was recently suggested that an "anti-ageing pill" is just around the corner, enabling humans to live to 150 and regenerate organs by 2020 very cheaply. But how excited should we be about such claims? Let's take a look at the evidence.

Since the time of the ancient Greeks people have argued about the relationship between ageing and disease. Today it seems probable that essentially all age related diseases are linked to the ageing process. Not all ageing changes are harmful though. In essence, we have a set of health maintenance mechanisms which act to keep us in good condition in the early part of our lives – problems arise as these start to fail with age. An anti-ageing pill would enhance one or more of these mechanisms and keep people healthy.

Main approaches

We now understand some of these major mechanisms. For example, , dysfunctional cells which build up as we age, are routinely formed and removed over time. This is a health maintenance mechanism which has evolved to keep us cancer free. However, when the removal of these cells fails, they cause damage to tissue – resulting in ageing and ill health. Removing them under laboratory conditions brings a raft of benefits.

The breakdown and synthesis of proteins is also essential to ageing. Partially degraded proteins can build up over time, compromising cellular function. Treatment with the drug rapamycin has been shown to boost normal protein turnover mechanisms – extending lifespan in mice and improving immune function in people.

As we age, our organs and tissues lose mass and gain waste products. When we are young, the periodic replenishment of cells within organs and tissues by the body's "reserve army" of uncommitted stem cells (cells that can become specialised cells) help keep us healthy, somewhat akin to drawing on your savings when your current account runs low. Stem cell therapy may therefore help counter ageing.

While delivery of grown outside the body remains difficult, there is evidence that activation of a class of proteins known as the sirtuins can enhance this stem cell maintenance. For example, treatment with the compound nicotinamide riboside enhances sirtuin activity and restores muscle stem cell function in mice, suggesting a route to treatment.

A variety of different molecules, some of which are found in the diet, are also able to stop mechanisms that compromise the ability of older people to resist acute physiological stress.

In addition to these mechanisms, scientists are beginning to shed light on how the mechanisms that coordinate brain and organ functions are disrupted by ageing and how this may be delayed in the future. But we already know enough today about at least some health maintenance processes to devise means of pepping them up.

Pills on the horizon?

Claims made in an article about recent research raising hopes for an anti-ageing pill by 2020 are not entirely false, but they aren't entirely accurate either. The hyperbole concerning nicotinamide riboside, which may restore muscle stem cell activity, is a case in point. It certainly is of considerable scientific interest, and is performing well in mice. But it lacks much relevant human data beyond the demonstration that levels can be safely increased by supplementation. Nobody has actually shown that these supplements make humans live longer or regrow their organs.

The vaunted 150-year lifespan is also slightly slippery. This is a 25% increase on the longest human lifespan ever and while the extent of lifespan extension is plausible for some experimental animals – such as mice with their senescent cells removed – starting with the maximum human lifespan of 120 and adding 25% inflates the figures to produce a "wow!" effect. Even if you accept that the same percentile extension seen in mice by one method would hold in humans using another, which is questionable, most of us woudln't live to 150 (there are less than a thousand people aged over 105 in the UK).

Ironically, this kind of story misses out on the genuinely exciting news that pharmaceutical companies are taking the idea of developing healthspan-enhancing drugs increasingly seriously. This is a notable shift in attitude, but the chasm between intention and achievement remains wide. In fact, humanity has only about 1,500 "molecular entities" (drugs) in its medicine chest.

This is because drug development is a costly and time consuming process. Ten years of work and US$2.5 billion would be a fair estimate of the price tag from start to finish. Worse still, when developing a drug for ageing, researchers face an additional problem: how do you know if it worked? A "typical" clinical trial lasts a year or two. Nobody is in a position to see if a putative wonder drug adds five or ten years to your lifespan, and who would you test it on anyway?

Fortunately, an elegant solution to this problem has been proposed. Targeting Aging with Metformin (or TAME) – developed in consultation with the FDA – is a new clinical trial protocol. TAME is based on the observation that the time at which an individual develops their initial age-related impairment, such as osteoporosis, diabetes or cardiovascular disease, is highly variable between different individuals (65 on average for heart attack). But the time from first to second impairment – for example, having diabetes and then developing cardiovascular problems – is much tighter, happening within a span of two to four years.

That means that a drug which improves health maintenance mechanisms will lengthen the period between first event and second event – making it possible to say if it has worked in a short time frame. This would allow companies to, in principle, prescribe a drug for ageing.

So do be sceptical about claims that you could live to 150 by taking a certain supplement right now – you won't be able to take an anti-aging pill tomorrow. But, excitingly, the fundamental scientific knowledge, translational strategies and many of the technologies to deliver one are available today.

Explore further: Bone drug protects stem cells from ageing

Related Stories

Bone drug protects stem cells from ageing

December 17, 2015
Stem cells can be protected from the effects of ageing by a drug currently used to treat patients with osteoporosis, a breakthrough study has found.

Science of why we age

February 12, 2018
Ageing is an accepted fact of life, trivialised and even glorified in books and movies. But why do we actually age? And can we stop it?

How does dietary restriction extend lifespan in flies?

April 17, 2018
Lifespan in flies is extended by limiting the activity of a group of proteins called GATA transcription factors (TFs), giving clues to how a moderate reduction in food intake protects against multiple ageing-related diseases, ...

Ageing linked to cancer

October 8, 2012
Ageing is an unavoidable part of life, and it is often accompanied by a number of age-related illnesses. One of the biggest diseases associated with ageing is cancer, which as a result is often referred to as a 'disease of ...

Recommended for you

For-profit hospitals correlated with higher readmission rates

September 19, 2018
Patients who receive care in a for-profit hospital are more likely to be readmitted than those who receive care in nonprofit or public hospitals, according to a new study published by University of Illinois at Chicago researchers.

Nearly half of resident physicians report burnout

September 18, 2018
Resident physician burnout in the U.S. is widespread, with the highest rates concentrated in certain specialties, according to research from Mayo Clinic, OHSU and collaborators. The findings appear on Tuesday, Sept. 18, in ...

Separated entry and exit doors for calcium keep energy production smooth in the powerhouses of heart cells

September 18, 2018
Stress demands the heart to work harder and faster. To keep pace, the muscle must make its fuel at an accelerated rate. Bursts of calcium entering mitochondria—the cell's powerhouses—normally help control energy output, ...

Sugar content of most supermarket yogurts well above recommended threshold

September 18, 2018
A comprehensive survey of ingredients in yogurts highlights high sugar levels in many—particularly organic yogurts and those marketed towards children.

First gut bacteria may have lasting effect on ability to fight chronic diseases

September 18, 2018
New research showing that the first bacteria introduced into the gut have a lasting impact may one day allow science to adjust microbiomes—the one-of-a-kind microbial communities that live in our gastrointestinal tracts—to ...

A new defender for your sense of smell

September 18, 2018
New research from the Monell Center increases understanding of a mysterious sensory cell located in the olfactory epithelium, the patch of nasal tissue that contains odor-detecting olfactory receptor cells. The findings suggest ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.